A PPARalpha promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes

Authors

Sharon Cresci, Washington University School of Medicine in St. LouisFollow
Janice M. Huss, City of Hope National Medical Center, Duarte, CaliforniaFollow
Amber L. Beitelshees, University of Maryland - BaltimoreFollow
Philip G. Jones, University of Missouri - Kansas CityFollow
Matt R. Minton, Washington University School of Medicine in St. Louis
Gerald W. Dorn II, Washington University School of Medicine in St. LouisFollow
Daniel P. Kelly, Burnham Institute for Medical Research, Orlando, FloridaFollow
John A. Spertus, University of Missouri - Kansas City
Howard L. McLeod, University of North Carolina at Chapel Hill

Journal

PLoS One

Publication Date

2010

Volume

5

Issue

9

Inclusive Pages

e12584

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0012584

Rights and Permissions

Cresci S, Huss JM, Beitelshees AL, Jones PG, Minton MR, et al. 2010 A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes. PLoS ONE 5(9): e12584. doi:10.1371/journal.pone.0012584

Recommended Citation

Cresci, Sharon; Huss, Janice M.; Beitelshees, Amber L.; Jones, Philip G.; Minton, Matt R.; Dorn, Gerald W. II; Kelly, Daniel P.; Spertus, John A.; and McLeod, Howard L., "A PPARalpha promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes." PLoS One. 5, 9. e12584. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/719